gallbladder disease and semaglutide Does Wegovy (semaglutide) increase the risk of disease? Semaglutide and Gallstones: Safety Guide
Description
The concern originates from long-term rodent studies on GLP-1 receptor agonists, where C-cell (parafollicular cell) hyperplasia was observed
For weight loss the recommended starting dose of Ozempic is 0.25 mg
however, it is FDA-approved for the treatment of type 2 diabetes , not for weight loss
We work with licensed U.S
GLP-1 medications, though generally safe and effective, can, in rare cases, be associated with severe gastrointestinal complications
This approach is tailored to each individual, delivering what mass-produced drugs cannot
